Medication · Also: GLP-1 receptor agonist, glucagon-like peptide-1

GLP-1

A class of medicines that mimic the gut hormone GLP-1 to lower blood sugar and reduce appetite.

A class of medicines that mimic the gut hormone GLP-1 to lower blood sugar and reduce appetite.

Also known as: GLP-1 receptor agonist, glucagon-like peptide-1

GLP-1 receptor agonists are medicines that act like the natural gut hormone glucagon-like peptide-1. They slow stomach emptying, curb appetite, and help regulate blood sugar.

FDA-approved examples include semaglutide and the dual GIP/GLP-1 agonist tirzepatide, marketed under several brand names for diabetes or weight management.

Related terms

Semaglutide

A GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management.

Tirzepatide

A dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and weight management.

Ozempic

A brand of injectable semaglutide FDA-approved to treat type 2 diabetes.

Wegovy

A brand of injectable semaglutide FDA-approved for chronic weight management.

Metformin

An oral medication for type 2 diabetes that improves the body’s response to insulin.

Source

DailyMed: GLP-1 receptor agonists

← Back to full glossary